James Snipes is a partner in the firm’s corporate practice and a former chair of the life sciences industry group. For the past twenty years, Mr. Snipes’s practice has focused on corporate and transactional matters for life sciences clients ranging from private, venture-backed biotech companies to multinational pharmaceutical companies. The focus of his practice is strategic collaborations and complex licensing transactions; acquisitions and divestitures; spin-outs; venture investments; and commercial agreements in the biopharmaceutical industry. Mr. Snipes’s international practice experience includes a stint as head of Covington’s corporate group in London and two years at one of Tokyo’s leading corporate law firms.
Mr. Snipes also advises a number of public and private companies and venture capital firms in the technology sector. Further, he is a recognized authority in the field of art law, with broad experience in resolving disputes involving Holocaust claims, cultural patrimony claims, and other collections-related issues.